In silico analysis of wild-type and mutant KRAS

The mutations of the KRAS gene at codons 12, 13, and 61 have been widely reported with different prognosis. In silico is one approach to explain the characteristics of the mutant genes. This study aimed to reveal the potential energy and fluctuations of the binding site and active site of wild-type...

Full description

Bibliographic Details
Main Authors: Frengki Frengki, Dedi Prima Putra, Fatma Sriwahyuni, Daan Khambri, Henni Vanda
Format: Article
Language:English
Published: Universitas Ahmad Dahlan 2019-05-01
Series:Pharmaciana
Subjects:
Online Access:http://journal.uad.ac.id/index.php/PHARMACIANA/article/view/11384/pdf_108
_version_ 1818597164109004800
author Frengki Frengki
Dedi Prima Putra
Fatma Sriwahyuni
Daan Khambri
Henni Vanda
author_facet Frengki Frengki
Dedi Prima Putra
Fatma Sriwahyuni
Daan Khambri
Henni Vanda
author_sort Frengki Frengki
collection DOAJ
description The mutations of the KRAS gene at codons 12, 13, and 61 have been widely reported with different prognosis. In silico is one approach to explain the characteristics of the mutant genes. This study aimed to reveal the potential energy and fluctuations of the binding site and active site of wild-type KRAS (KRAS Wt) and mutant KRAS (KRAS Mt) at codons 12, 13, and 61. The samples used in this study were the sequences of KRAS Wt and KRAS Mt genes, which were subjected to in-silico analysis that included molecular homology, docking, and dynamics using MOE, PyMOL, and online CABS servers. The results showed that fluctuations in the binding site of all KRAS Mt were lower than that of KRAS Wt. On the contrary, the active site (switch I and switch II) of KRAS Mt fluctuated more widely than KRAS Wt. The potential energy of KRAS Mt before forming a complex with GTP was higher (p<0.01) than KRAS Wt. After this formation, it remained higher at codons 12 and 61 but lower at codons 11 and 13 (p <0.001). Mt G12A did not show any changes. The higher fluctuations in the switch I and switch II regions and the post energy of KRAS-GTP complexes may explain why types of cancers with mutations at codons 11 and 13 have a better prognosis than those with mutations at codons 12 and 61.
first_indexed 2024-12-16T11:43:27Z
format Article
id doaj.art-4f059cb3a7ce4509b1b4d5328e4fd7e5
institution Directory Open Access Journal
issn 2088-4559
2477-0256
language English
last_indexed 2024-12-16T11:43:27Z
publishDate 2019-05-01
publisher Universitas Ahmad Dahlan
record_format Article
series Pharmaciana
spelling doaj.art-4f059cb3a7ce4509b1b4d5328e4fd7e52022-12-21T22:32:53ZengUniversitas Ahmad DahlanPharmaciana2088-45592477-02562019-05-0191899810.12928/pharmaciana.v9i1.11384In silico analysis of wild-type and mutant KRASFrengki Frengki0Dedi Prima Putra 1Fatma Sriwahyuni2Daan Khambri3Henni Vanda4Biomedicine Faculty of Medicine of Andalas University, Padang, IndonesiaFaculty of Pharmacy Andalas University, PadangFaculty of Pharmacy Andalas University, PadangBiomedicine Faculty of Medicine of Andalas University, PadangFaculty of Veterinary Medicine of Syiah Kuala University, Banda AcehThe mutations of the KRAS gene at codons 12, 13, and 61 have been widely reported with different prognosis. In silico is one approach to explain the characteristics of the mutant genes. This study aimed to reveal the potential energy and fluctuations of the binding site and active site of wild-type KRAS (KRAS Wt) and mutant KRAS (KRAS Mt) at codons 12, 13, and 61. The samples used in this study were the sequences of KRAS Wt and KRAS Mt genes, which were subjected to in-silico analysis that included molecular homology, docking, and dynamics using MOE, PyMOL, and online CABS servers. The results showed that fluctuations in the binding site of all KRAS Mt were lower than that of KRAS Wt. On the contrary, the active site (switch I and switch II) of KRAS Mt fluctuated more widely than KRAS Wt. The potential energy of KRAS Mt before forming a complex with GTP was higher (p<0.01) than KRAS Wt. After this formation, it remained higher at codons 12 and 61 but lower at codons 11 and 13 (p <0.001). Mt G12A did not show any changes. The higher fluctuations in the switch I and switch II regions and the post energy of KRAS-GTP complexes may explain why types of cancers with mutations at codons 11 and 13 have a better prognosis than those with mutations at codons 12 and 61.http://journal.uad.ac.id/index.php/PHARMACIANA/article/view/11384/pdf_108fluctuationsin silicokraspolymorphismpotential energy
spellingShingle Frengki Frengki
Dedi Prima Putra
Fatma Sriwahyuni
Daan Khambri
Henni Vanda
In silico analysis of wild-type and mutant KRAS
Pharmaciana
fluctuations
in silico
kras
polymorphism
potential energy
title In silico analysis of wild-type and mutant KRAS
title_full In silico analysis of wild-type and mutant KRAS
title_fullStr In silico analysis of wild-type and mutant KRAS
title_full_unstemmed In silico analysis of wild-type and mutant KRAS
title_short In silico analysis of wild-type and mutant KRAS
title_sort in silico analysis of wild type and mutant kras
topic fluctuations
in silico
kras
polymorphism
potential energy
url http://journal.uad.ac.id/index.php/PHARMACIANA/article/view/11384/pdf_108
work_keys_str_mv AT frengkifrengki insilicoanalysisofwildtypeandmutantkras
AT dediprimaputra insilicoanalysisofwildtypeandmutantkras
AT fatmasriwahyuni insilicoanalysisofwildtypeandmutantkras
AT daankhambri insilicoanalysisofwildtypeandmutantkras
AT hennivanda insilicoanalysisofwildtypeandmutantkras